sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
North America Transfection Reagents and Equipment Market , Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America Transfection Reagents and Equipment Market , Companies Profiles,...

Home / Categories / Healthcare
North America Transfection Reagents and Equipment Market , Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
North America Transfection Reagents and...
Report Code
RO1/110/1213

Publish Date
01/Jun/2018

Pages
100
PRICE
$ 2500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3200/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table Of Contents
1 Introduction 12
1.1 Objectives Of The Study 12
1.2 Market Definition 12
1.3 Overview Of Global Transfection Reagents And Equipment Market 12
1.4 Currency And Pricing 13
1.5 Limitation 13
1.6 Markets Covered 14
2 Market Segmentation 16
2.1 Markets Covered 16
2.2 Geographic Scope 17
2.3 Years Considered For The Study 18
2.4 Currency And Pricing 18
2.5 Research Methodology 19
2.6 Primary Interviews With Key Opinion Leaders 22
2.7 The Category Vs Time Grid 23
2.8 Secondary Sources 26
2.9 Assumptions 26
3 Market Overview 27
3.1 Drivers 29
3.1.1 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes 29
3.1.2 Increasing R&D Spending And Research Activities By Pharmaceutical And Biotech Companies 30
3.1.3 Technological Advancements In Transfection Technology 31
3.1.4 Alliances Between The Leading Research Institutes To Trigger Drug Discovery 32
3.1.5 Rising Prevalence Of Chronic Indications 32
3.2 Restraints 34
3.2.1 Selective Effectiveness Of Transfection Reagents Or Instruments 34
3.2.2 High Cost Of Transfection Reagents And Equipment 34
3.2.3 Home Brew Reagents Limits The Sale Of Commercial Kits 36
3.3 Opportunities 37
3.3.1 Efficient Nuclear Delivery Method 37
3.3.2 Emerging Markets 37
3.4 Challenges 39
3.4.1 Slow Rate Of Transfection In Hard Cells 39
3.4.2 Cytotoxicity Effects Due To Transfection Reagents 39
4 Executive Summary 40
5 Premium Insights 42
6 Global Transfection Reagents And Equipment Market, By Product 45
6.1 Overview 46
6.2 Reagent 48
6.3 Equipment 49
7 Global Transfection Reagents And Equipment Market, By Method 50
7.1 Overview 51
7.2 Physical Method 53
7.2.1 Electroporation 54
7.2.2 Nucleofection 54
7.2.3 Others 54
7.2.3.1 Genegun 55
7.2.3.2 Magnetofection 55
7.2.3.3 Sonoporation 55
7.2.3.4 Optoinjection 55
7.3 Biochemical Methods 56
7.3.1 Lipofection 57
7.3.2 Calcium Phosphate 57
7.3.3 Deae-Dextran 57
7.3.4 Dendrimers 57
7.4 Viral Method 58
7.4.1 Retroviruses 59
7.4.2 Adenoviruses 59
7.4.3 Adenoassociated Viruses 59
7.4.4 Others 59
8 Global Transfection Reagents And Equipment Market, By Application 60
8.1 Overview 61
8.2 Protein Production 63
8.3 Biomedical Research 64
8.3.1 Gene Expression Studies 65
8.3.2 Cancer Research 65
8.3.3 Transgenic Models 65
8.4 Therapeutic Delivery 66
9 Global Transfection Reagents And Equipment Market, By End User 67
9.1 Overview 68
9.2 Academics & Research Institutes 70
9.3 Pharmaceutical & Biotechnology Companies 71
10 Global Transfection Reagents And Equipment, By Geography 72
10.1 North America 72
10.1.1 U.S. 82
10.1.2 Canada 87
10.1.3 Mexico 92
11 Global Transfection Reagents And Equipment Market, Company Landscape 97
11.1 Company Share Analysis; North America 97
12 Company Profile 98
12.1 Thermo Fisher Scientific Inc. 98
12.1.1 Company Overview 98
12.1.2 Revenue Analysis 98
12.1.3 Company Share Analysis 99
12.1.4 Product Portfolio 99
12.1.5 Recent Developments 100
12.2 Sigma-Aldrich, Inc. (Subsidiary Of Merck Kgaa) 101
12.2.1 Company Overview 101
12.2.2 Geographical Presence 101
12.2.3 Company Share Analysis 102
12.2.4 Product Portfolio 102
12.2.5 Recent Developments 102
12.3 Promega Corporation 103
12.3.1 Company Overview 103
12.3.2 Geographical Presence 103
12.3.3 Company Share Analysis 104
12.3.4 Product Portfolio 104
12.3.5 Recent Developments 104
12.4 Qiagen 105
12.4.1 Company Overview 105
12.4.2 Revenue Analysis 105
12.4.3 Company Share Analysis 106
12.4.4 Product Portfolio 106
12.4.5 Recent Developments 107
12.5 Bio-Rad Laboratories, Inc. 108
12.5.1 Company Overview 108
12.5.2 Revenue Analysis 108
12.5.3 Product Portfolio 109
12.5.4 Recent Developments 109
12.6 Genlantis Inc. 110
12.6.1 Company Overview 110
12.6.2 Geographical Presence 110
12.6.3 Product Portfolio 111
12.6.4 Recent Developments 111
12.7 Lonza 112
12.7.1 Company Overview 112
12.7.2 Revenue Analysis 112
12.7.3 Product Portfolio 113
12.7.4 Recent Developments 114
12.8 Maxcyte Inc 115
12.8.1 Company Overview 115
12.8.2 Geographical Presence 115
12.8.3 Product Portfolio 116
12.8.4 Recent Developments 116
12.9 Mirus Bio Llc 117
12.9.1 Company Overview 117
12.9.2 Geographical Presence 117
12.9.3 Product Portfolio 118
12.9.4 Recent Developments 119
12.10 Polyplus Transfection 120
12.10.1 Company Overview 120
12.10.2 Geographical Presence 120
12.10.3 Product Portfolio 121
12.10.4 Recent Developments 121
12.11 Signagen Laboratories. 122
12.11.1 Company Overview 122
12.11.2 Geographical Presence 122
12.11.3 Product Portfolio 123
12.11.4 Recent Development 123
13 Related Reports 124
?

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com